Some healthcare and technology firms are reportedly partnering to collect coronavirus patient information to assist government and academic researchers. Such efforts are raising significant security and privacy concerns. The FDA says it recognizes potential for many different real-world data sources to complement traditional clinical studies and speed the process of evaluating the impact of potential COVID-19 therapies. Privacy expert: “Consider this data extremely sensitive, and privacy is of the utmost critical needs utmost need The collected data will be considered high velocity data often changing and growing by the hour.”]
Source: https://www.govinfosecurity.com/using-covid-19-patient-data-for-research-sizing-up-risks-a-14111